pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

In-patient cardiac pre-hab program launched to keep heart-transplant candidates fit while awaiting surgery

Aug 3, 2026·read at STAT ↗Positive

Patients waiting in the hospital for a heart transplant often lose strength and can become ineligible for the procedure as their fitness declines.

To address this, Dr. Radha Gopalan at Banner‑University Medical Center Phoenix has introduced an inpatient cardiac pre‑habilitation program. The initiative targets transplant candidates who are hospitalized for worsening heart failure, arrhythmias, or coronary artery disease.

The program adapts elements of traditional cardiac rehab and outpatient prehab, providing supervised exercise and conditioning while patients remain in‑patient. Organizers hope it will preserve functional capacity, reduce disqualification rates, and improve outcomes after transplantation.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Heart transplant candidates fail if they get too weak. New program tries inpatient prehab”

read at STAT ↗
1,076 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING3Ultragenyx Pharmaceutical Inc.
drugs
Rare Disease
topics
Cardiology20Endocrinology & Metabolism3Heart Failure2Pulmonology2Rare Disease

related stories

  • 5d agoGSK cost-cutting plan includes global layoffsBioSpace
  • 6d agoAstraZeneca has no plans to ramp up dealmaking in wake of Wainua failureBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 3d agoNovo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 failFierce Biotech
  • 4d agoNew funding, new jobs: 4 biotechs hiring after series B raisesBioSpace